Global Active Pharmaceutical Ingredients (API) Market Research Report 2020

Publisher Name :
Date: 07-Jan-2020
No. of pages: 134
Inquire Before Buying

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market

The global Active Pharmaceutical Ingredients (API) market is valued at 63210 million US$ in 2020 is expected to reach 99230 million US$ by the end of 2026, growing at a CAGR of 6.6% during 2021-2026.

Global Active Pharmaceutical Ingredients (API) Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert's opinions have been taken to understand the market better.

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Synthetic APIs

- Biotech APIs

Segment by Application

- CNS

- Cardiovascular

- Genitourinary/Hormonal Drugs

- Respiratory

- Rheumatology

- Diabetes

- Oncology

- Others

Global Active Pharmaceutical Ingredients (API) Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Active Pharmaceutical Ingredients (API) market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Active Pharmaceutical Ingredients (API) Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

The major players in the market include Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, Sun Pharmaceutical Industries, Zhejiang Medicine, Dr. Reddy's Laboratories, Zhejiang NHU, Bayer, NCPC, AbbVie, Shandong Xinhua Pharmaceutical, Northeast Pharm, Harbin Pharmaceutical, LKPC, etc.

Global Active Pharmaceutical Ingredients (API) Market Research Report 2020

Table of Contents
1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Active Pharmaceutical Ingredients (API) Consumption Comparison by Application: 2020 VS 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Active Pharmaceutical Ingredients (API) Market by Region
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Active Pharmaceutical Ingredients (API) Growth Prospects
1.5.1 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
2.6 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.6.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Active Pharmaceutical Ingredients (API) Market Share by Regions (2015-2020)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions (2015-2020)
3.3 Global Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Active Pharmaceutical Ingredients (API) Production
3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.4.2 North America Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Active Pharmaceutical Ingredients (API) Production
3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Active Pharmaceutical Ingredients (API) Production
3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.6.2 China Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Active Pharmaceutical Ingredients (API) Production
3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.7.2 Japan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
4.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region
4.2 North America
4.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Active Pharmaceutical Ingredients (API) Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2015-2020)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2015-2020)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2015-2020)
5.4 Global Active Pharmaceutical Ingredients (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Active Pharmaceutical Ingredients (API) Market Analysis by Application
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
7.1 Teva
7.1.1 Teva Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.1.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Main Business and Markets Served
7.2 Mylan
7.2.1 Mylan Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.2.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Main Business and Markets Served
7.3 DSM
7.3.1 DSM Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.3.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Main Business and Markets Served
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.4.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.5 Aspen
7.5.1 Aspen Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.5.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Main Business and Markets Served
7.6 Novartis
7.6.1 Novartis Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.6.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Main Business and Markets Served
7.7 BASF
7.7.1 BASF Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.7.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.8 Pfizer
7.8.1 Pfizer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.8.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Main Business and Markets Served
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.9.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Main Business and Markets Served
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.10.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Main Business and Markets Served
7.11 Sun Pharmaceutical Industries
7.11.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.11.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.11.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Main Business and Markets Served
7.12 Zhejiang Medicine
7.12.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.12.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.12.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Main Business and Markets Served
7.13 Dr. Reddy's Laboratories
7.13.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.13.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.13.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Main Business and Markets Served
7.14 Zhejiang NHU
7.14.1 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.14.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.14.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Main Business and Markets Served
7.15 Bayer
7.15.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.15.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.15.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 Main Business and Markets Served
7.16 NCPC
7.16.1 Bayer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.16.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.16.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.16.4 Main Business and Markets Served
7.17 AbbVie
7.17.1 NCPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.17.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.17.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.17.4 Main Business and Markets Served
7.18 Shandong Xinhua Pharmaceutical
7.18.1 AbbVie Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.18.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.18.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.18.4 Main Business and Markets Served
7.19 Northeast Pharm
7.19.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.19.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.19.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.19.4 Main Business and Markets Served
7.20 Harbin Pharmaceutical
7.20.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.20.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.20.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.20.4 Main Business and Markets Served
7.21 LKPC
7.21.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.21.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.21.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.21.4 Main Business and Markets Served
.1 LKPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
.4 Main Business and Markets Served
8 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
8.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Active Pharmaceutical Ingredients (API) Distributors List
9.3 Active Pharmaceutical Ingredients (API) Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) (2021-2026)
11.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) (2021-2026)
11.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) (2021-2026)
11.4 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions (2021-2026)
11.4.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.2 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.3 China Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.4 Japan Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Fprecast
12.1 Global Forecasted and Consumption Demand Analysis of Active Pharmaceutical Ingredients (API)
12.2 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.4 Asia Pacific Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Regions
12.5 Latin America Forecasted Consumption of Active Pharmaceutical Ingredients (API)
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.1.2 Global Forecasted Price of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2021-2026)
14 Reseach Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Active Pharmaceutical Ingredients (API) Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 3. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Comparison by Application: 2020 VS 2026
Table 4. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Manufacturers
Table 5. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Manufacturers (2015-2020)
Table 6. Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers (2015-2020)
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
Table 10. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients (API) Product Types
Table 13. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14.Mergers & Acquisitions, Expansion
Table 15. Global Active Pharmaceutical Ingredients (API) Capacity (K MT) by Region (2015-2020)
Table 16. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Region (2015-2020)
Table 17. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Region (2015-2020)
Table 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Table 19. Global Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 20. North America Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 21. Europe Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 22. China Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 23. Japan Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 24. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Market by Region (2015-2020)
Table 25. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2015-2020)
Table 26. North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 27. Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 28. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 29. Latin America Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 30. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Type (2015-2020)
Table 31. Global Active Pharmaceutical Ingredients (API) Production Share by Type (2015-2020)
Table 32. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Type (2015-2020)
Table 33. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)
Table 34. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Type (2015-2020)
Table 35. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) by Application (2015-2020)
Table 36. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
Table 37. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2015-2020)
Table 38. Teva Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 39. Teva Production Sites and Area Served
Table 40. Teva Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 41. Teva Main Business and Markets Served
Table 42. Mylan Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 43. Mylan Production Sites and Area Served
Table 44. Mylan Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 45. Mylan Main Business and Markets Served
Table 46. DSM Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 47. DSM Production Sites and Area Served
Table 48. DSM Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 49. DSM Main Business and Markets Served
Table 50. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 51. Aurobindo Pharma Production Sites and Area Served
Table 52. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 53. Aurobindo Pharma Main Business and Markets Served
Table 54. Aspen Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 55. Aspen Production Sites and Area Served
Table 56. Aspen Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 57. Aspen Main Business and Markets Served
Table 58. Novartis Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 59. Novartis Production Sites and Area Served
Table 60. Novartis Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Novartis Main Business and Markets Served
Table 62. BASF Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 63. BASF Production Sites and Area Served
Table 64. BASF Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 65. BASF Main Business and Markets Served
Table 66. Pfizer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 67. Pfizer Production Sites and Area Served
Table 68. Pfizer Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 69. Pfizer Main Business and Markets Served
Table 70. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 71. Huahai Pharmaceutical Production Sites and Area Served
Table 72. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Huahai Pharmaceutical Main Business and Markets Served
Table 74. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 75. Hisun Pharmaceutical Production Sites and Area Served
Table 76. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Hisun Pharmaceutical Main Business and Markets Served
Table 78. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 79. Sun Pharmaceutical Industries Production Sites and Area Served
Table 80. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Sun Pharmaceutical Industries Main Business and Markets Served
Table 82. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 83. Zhejiang Medicine Production Sites and Area Served
Table 84. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Zhejiang Medicine Main Business and Markets Served
Table 86. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 87. Dr. Reddy's Laboratories Production Sites and Area Served
Table 88. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Dr. Reddy's Laboratories Main Business and Markets Served
Table 90. Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 91. Zhejiang NHU Production Sites and Area Served
Table 92. Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Zhejiang NHU Main Business and Markets Served
Table 94. Bayer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 95. Bayer Production Sites and Area Served
Table 96. Bayer Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bayer Main Business and Markets Served
Table 98. NCPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 99. NCPC Production Sites and Area Served
Table 100. NCPC Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. NCPC Main Business and Markets Served
Table 102. AbbVie Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 103. AbbVie Production Sites and Area Served
Table 104. AbbVie Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AbbVie Main Business and Markets Served
Table 106. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 107. Shandong Xinhua Pharmaceutical Production Sites and Area Served
Table 108. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Shandong Xinhua Pharmaceutical Main Business and Markets Served
Table 110. Northeast Pharm Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 111. Northeast Pharm Production Sites and Area Served
Table 112. Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Northeast Pharm Main Business and Markets Served
Table 114. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 115. Harbin Pharmaceutical Production Sites and Area Served
Table 116. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Harbin Pharmaceutical Main Business and Markets Served
Table 118. LKPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 119. LKPC Production Sites and Area Served
Table 120. LKPC Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. LKPC Main Business and Markets Served
Table 122. Production Base and Market Concentration Rate of Raw Material
Table 123. Key Suppliers of Raw Materials
Table 124. Active Pharmaceutical Ingredients (API) Distributors List
Table 125. Active Pharmaceutical Ingredients (API) Customers List
Table 126. Market Key Trends
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Global Active Pharmaceutical Ingredients (API) Production (K MT) Forecast by Region (2021-2026)
Table 130. North America Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 131. Europe Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 132. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Regions
Table 133. Latin America Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 134. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Forecast by Regions (2021-2026)
Table 135. Global Active Pharmaceutical Ingredients (API) Production (K MT) Forecast by Type (2021-2026)
Table 136. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) Forecast by Type (2021-2026)
Table 137. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) Forecast by Type (2021-2026)
Table 138. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Forecast by Application (2021-2026)
Table 139.Research Programs/Design for This Report
Table 140.Key Data Information from Secondary Sources
Table 141.Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Active Pharmaceutical Ingredients (API)
Figure 2. Global Active Pharmaceutical Ingredients (API) Production Market Share by Type: 2020 VS 2026
Figure 3. Synthetic APIs Product Picture
Figure 4. Biotech APIs Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application: 2020 VS 2026
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. North America Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Europe Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 16. China Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 17. Japan Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 18. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) (2015-2026)
Figure 19. Global Active Pharmaceutical Ingredients (API) Production Capacity (K MT) (2015-2026)
Figure 20. Active Pharmaceutical Ingredients (API) Production Share by Manufacturers in 2019
Figure 21. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2019
Figure 22. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Manufacturers in 2019
Figure 24. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2019
Figure 25. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2015-2020)
Figure 26. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region in 2019
Figure 27. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Figure 28. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2019
Figure 29. Global Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 30. North America Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 31. Europe Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 32. China Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
  • Dextran - Global Market Insights and Sales Trends 2024 -2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 122
    The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......
  • Global Corticosteroids API Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 162
    The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029. North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029. Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......
  • Global HPLC Columns Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 149
    The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029. The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue. Report Scope This r......
  • Global Inorganic Advanced Phase Change Materials Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030. North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Inorganic Advanced Phase Ch......
  • Global Material Jetting 3D Printing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......
  • Global Halogen Free Material Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 81
    The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Silicone Adhesives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 101
    The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030. North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......
  • Global Paraffin Hydrotreating Catalyst Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91
    The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......
  • Global Stained Glass Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs